- Home
- BNGO vs VOR Comparison
BNGO vs VOR Comparison
Compare BNGO & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- VOR
- Stock Information
- Founded
- BNGO 2003
- VOR 2015
- Country
- BNGO United States
- VOR United States
- Employees
- BNGO N/A
- VOR N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- VOR Health Care
- Exchange
- BNGO Nasdaq
- VOR Nasdaq
- Market Cap
- BNGO 24.3M
- VOR 22.1M
- IPO Year
- BNGO 2018
- VOR 2021
- Fundamental
- Price
- BNGO $3.29
- VOR $0.89
- Analyst Decision
- BNGO Buy
- VOR Buy
- Analyst Count
- BNGO 5
- VOR 7
- Target Price
- BNGO $7.33
- VOR $6.07
- AVG Volume (30 Days)
- BNGO 73.9K
- VOR 30.9M
- Earning Date
- BNGO 08-06-2025
- VOR 08-07-2025
- Dividend Yield
- BNGO N/A
- VOR N/A
- EPS Growth
- BNGO N/A
- VOR N/A
- EPS
- BNGO N/A
- VOR N/A
- Revenue
- BNGO $28,464,000.00
- VOR N/A
- Revenue This Year
- BNGO N/A
- VOR N/A
- Revenue Next Year
- BNGO $15.54
- VOR N/A
- P/E Ratio
- BNGO N/A
- VOR N/A
- Revenue Growth
- BNGO N/A
- VOR N/A
- 52 Week Low
- BNGO $2.68
- VOR $0.13
- 52 Week High
- BNGO $44.94
- VOR $1.80
- Technical
- Relative Strength Index (RSI)
- BNGO 38.04
- VOR 87.39
- Support Level
- BNGO $3.18
- VOR $0.29
- Resistance Level
- BNGO $3.88
- VOR $0.23
- Average True Range (ATR)
- BNGO 0.17
- VOR 0.11
- MACD
- BNGO -0.02
- VOR 0.07
- Stochastic Oscillator
- BNGO 18.33
- VOR 65.71
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.